Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North America Today.
Press releases published on August 17, 2025
Joint Sealants Market Trends, Growth Drivers & Opportunities,2031
An increase in demand for joint sealants in a range of industries such as construction, transportation, aerospace, healthcare the global joint sealants market. WILMINGTON, DE, UNITED STATES, August 17, 2025 /EINPresswire.com/ -- Allied Market Research …
Diaspora Voting Discussion Receive Loudest Applause from Nigerians in US at Virtual Townhall with Embassy Officials
The Second Virtual Townhall hosted by the Nigeria Mission in D.C, along with the Consulates in New York and Atlanta was largely considered a Success WASHINGTON, DC, UNITED STATES, August 17, 2025 /EINPresswire.com/ -- Considered by the host and …
Audfly’s Miniature High-Performance Directional Sound Modules Poised to Reshape Audio Integration Design
LOS ANGELES, CA, UNITED STATES, August 17, 2025 /EINPresswire.com/ -- The integration of high-precision audio into ever-smaller devices has long challenged product designers. In recent weeks, China-based audio innovator Audfly Technology unveiled several …
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Flywire Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLYW
NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Flywire Corporation (NASDAQ: FLYW) between February 28, 2024 and February 25, 2025, both dates inclusive (the “Class …
Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, …
Studycat expands accent‑rich voice training for young learners in children Spanish language Android app
Fun Spanish for Android now offers enhanced accent-rich voices and interactive speaking challenges to help kids playfully improve Spanish pronunciation. HK, HONG KONG, August 17, 2025 /EINPresswire.com/ -- Studycat, the award‑winning creator of language …
PageUp Infuses AI Across its Hiring Platform to Automate Repetitive Tasks and Accelerate Smart Hiring
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- PageUp, a global leader in talent acquisition software, today announced the launch of advanced AI features across its recruitment marketing platform, PageUp Clinch, and its Applicant Tracking System (PageUp ATS). …
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages CTO Realty Growth, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CTO, CTO-PA
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of CTO Realty Growth, Inc. (NYSE: CTO, CTO-PA) between February 18, …
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Spectrum Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SPPI
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces the reopening of the Lead Plaintiff appointment process in a pending securities class action lawsuit on behalf of investors of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the “Company …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Groupon, Inc. - GRPN
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Groupon, Inc. (“Groupon” or the “Company”) (NASDAQ: GRPN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Designer Brands Inc. - DBI
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Designer Brands Inc. (“Designer Brands” or the “Company”) (NYSE: DBI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KBR, Inc. - KBR
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of KBR, Inc. (“KBR” or the “Company”) (NYSE: KBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”) (NASDAQ: EWTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY). Such investors are advised to contact Danielle Peyton at newaction@ …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX
NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of argenx SE (“argenx” or the “Company”) (NASDAQ: ARGX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …